Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AA24493 in Friedreich's Ataxia
NCT01016366Phase 2Completed
- Sponsor
- Lundbeck
- Start
- Oct 2009
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 2 trial of carbamoylated erythropoietin in Friedreich's ataxia (FA), sponsored by Lundbeck. Started Oct 2009; status: completed.
02
Drugs
carbamoylated erythropoietin
03
Conditions
Friedreich's ataxia (FA)
Beyond the preview
Go deeper on NCT01016366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01016366.